Lenacapavir Impurity 10 - Request Quote
Lenacapavir Impurity 10
| SZ CAT No: | SZ-L105011 |
| CAS No | NA |
| Mol.F. | C29H24BrF7N4O3S |
| Mol.Wt. | 721.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lenacapavir Impurity 10 is chemically N-((R)-1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bR,4aS)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide. Lenacapavir Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Lenacapavir Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenacapavir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lenacapavir Impurity 10
Purchase Lenacapavir Impurity 10
Lenacapavir Impurity 10 suppliers
Lenacapavir Impurity 10 manufacturers
Lenacapavir Impurity 10 price
Order Lenacapavir Impurity 10
Enquire Lenacapavir Impurity 10
Lenacapavir Impurity 10 cost
Lenacapavir Impurity 10 Supplier
Lenacapavir Impurity 10 Distributor
Lenacapavir Impurity 10 for Method Validation
Lenacapavir Reference Standard
Lenacapavir Impurity 10 for ANDA Filing
Lenacapavir Impurity 10 for Forced Degradation Studies
Lenacapavir Impurity 10 Identification Standards
Lenacapavir Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.